WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the Society for Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuczenski, R.
Right arrow Articles by Melega, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuczenski, R.
Right arrow Articles by Melega, W.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 15, 1308-1317, Copyright © 1995 by Society for Neuroscience


ARTICLE

Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine

R Kuczenski, DS Segal, AK Cho and W Melega
Psychiatry Department, UC San Diego School of Medicine, La Jolla 92093- 0603.

Microdialysis in behaving animals was used to concomitantly characterize the dopamine and 5-HT responses in the caudate and the norepinephrine response in the hippocampus to the D- and L-isomers of amphetamine and methamphetamine. Doses of all four drugs which promoted similar stereotypy responses produced a D-amphetamine-like response profile of dopamine and dopamine metabolites, suggesting that all these drugs interact with dopamine systems to facilitate the release of transmitter. However, in contrast to the similar behavioral profiles, the magnitude of the dopamine responses diverged significantly. In addition, all four drugs increased extracellular norepinephrine and 5- HT, but the relative responses differed markedly from dopamine and from each other. The contrasting structure-activity relationships for these drugs likely reflect their differential potency at the various neuronal uptake transporters in promoting either transmitter release, and/or uptake blockade. In addition, the interaction of each drug at the vesicular transporters, as well as the availability of a cytoplasmic pool of transmitter likely also contribute to the neurotransmitter response. Because of the particularly divergent transmitter response profiles exhibited by L-methamphetamine, its behavioral and neurotransmitter effects were characterized over a more extended range of doses. Although the duration of the increase in extracellular dopamine was clearly proportional to dose, the dose-dependent increases in the magnitude of the dopamine response did not parallel the behavioral profiles. The results of these studies indicate that, while the dopamine, norepinephrine and 5-HT responses to these drugs probably contribute to the expression of stimulant-induced behaviors, simple relationships between the neurotransmitter responses and the behavioral profiles were not evident.


This article has been cited by other articles:


Home page
StrokeHome page
C. M. Papadopoulos, S.-Y. Tsai, V. Guillen, J. Ortega, G. L. Kartje, and W. A. Wolf
Motor Recovery and Axonal Plasticity With Short-Term Amphetamine After Stroke
Stroke, January 1, 2009; 40(1): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. S. Fowler, C. Kroll, R. Ferrieri, D. Alexoff, J. Logan, S. L. Dewey, W. Schiffer, D. Schlyer, P. Carter, P. King, et al.
PET Studies of d-Methamphetamine Pharmacokinetics in Primates: Comparison with l-Methamphetamine and ( )-Cocaine
J. Nucl. Med., October 1, 2007; 48(10): 1724 - 1732.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. W. Czoty, C. R. Ramanathan, N. H. Mutschler, A. Makriyannis, and J. Bergman
Drug Discrimination in Methamphetamine-Trained Monkeys: Effects of Monoamine Transporter Inhibitors
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 720 - 727.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Justinova, S. Ferre, P. N. Segal, K. Antoniou, M. Solinas, L. A. Pappas, J. L. Highkin, J. Hockemeyer, P. Munzar, and S. R. Goldberg
Involvement of Adenosine A1 and A2A Receptors in the Adenosinergic Modulation of the Discriminative-Stimulus Effects of Cocaine and Methamphetamine in Rats
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 977 - 986.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Sandoval, E. L. Riddle, G. R. Hanson, and A. E. Fleckenstein
Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic Deficits
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1181 - 1187.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. H. Baumann, M. A. Ayestas, L. G. Sharpe, D. B. Lewis, K. C. Rice, and R. B. Rothman
Persistent Antagonism of Methamphetamine-Induced Dopamine Release in Rats Pretreated with GBR12909 Decanoate
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1190 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
L. K. Tremblay, C. A. Naranjo, L. Cardenas, N. Herrmann, and U. E. Busto
Probing Brain Reward System Function in Major Depressive Disorder: Altered Response to Dextroamphetamine
Arch Gen Psychiatry, May 1, 2002; 59(5): 409 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. K. Miller, P. A. Crooks, L. Teng, J. M. Witkin, P. Munzar, S. R. Goldberg, J. B. Acri, and L. P. Dwoskin
Lobeline Inhibits the Neurochemical and Behavioral Effects of Amphetamine
J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 1023 - 1034.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. R. Metzger, H. M. Haughey, D. G. Wilkins, J. W. Gibb, G. R. Hanson, and A. E. Fleckenstein
Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1077 - 1085.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Segal and R. Kuczenski
Escalating Dose-Binge Treatment with Methylphenidate: Role of Serotonin in the Emergent Behavioral Profile
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 19 - 30.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Munzar, M. D. Laufert, S. W. Kutkat, J. Nováková, and S. R. Goldberg
Effects of Various Serotonin Agonists, Antagonists, and Uptake Inhibitors on the Discriminative Stimulus Effects of Methamphetamine in Rats
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 239 - 250.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
W. P. Melega, A. K. Cho, D. Schmitz, R. Kuczenski, and D. S. Segal
l-Methamphetamine Pharmacokinetics and Pharmacodynamics for Assessment of In Vivo Deprenyl-Derived l-Methamphetamine
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 752 - 758.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. P. Gygi, A. E. Fleckenstein, J. W. Gibb, and G. R. Hanson
Role of Endogenous Dopamine in the Neurochemical Deficits Induced by Methcathinone
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1350 - 1355.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
E. D. Abercrombie and P. DeBoer
Substantia Nigra D1 Receptors and Stimulation of Striatal Cholinergic Interneurons by Dopamine: A Proposed Circuit Mechanism
J. Neurosci., November 1, 1997; 17(21): 8498 - 8505.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Segal and R. Kuczenski
Repeated Binge Exposures to Amphetamine and Methamphetamine: Behavioral and Neurochemical Characterization
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 561 - 573.
[Abstract] [Full Text]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-